Please be aware that this website may contain images, voices or names of deceased persons in the photographs, film, audio recordings or printed material.
Aboriginal and Torres Strait Islander peoples are significantly and disproportionately burden by diabetes and cardiovascular disease.
These chronic conditions, particularly when undiagnosed or poorly managed, not only cause suffering and disability, but are also some of the leading causes of death for Aboriginal and Torres Strait Islander peoples in Australia.
Heart disease was the leading cause of death for Aboriginal and Torres Strait Islander people in 2018, followed by diabetes as the second leading cause of death for Aboriginal and Torres Strait Islander peoples. With reported cases of both D&CVD either remaining steady, as is the case for diabetes, or rising in the case of cardiovascular disease, research into the diagnosis and management of these diseases has become a key focus of state, territory and Commonwealth governments of Australia.
The Targeted Translation Research Accelerator program provides an integrated research program to improve the prevention, management and treatment of diabetes and cardiovascular disease (D&CVD) and their related complications in Australia. The $47 million TTRA program is funded through the Preventative and Public Health Research initiative of the Medical Research Future Fund (MRFF) and is being delivered by MTPConnect.
Lowitja Institute was engaged to facilitate the needs assessment process for this round to determine the Indigenous-specific priority areas for research into D&CVD. In doing this, we have assessed and prioritised the related unmet health and medical needs of Aboriginal and Torres Strait Islander people in rural, remote, regional, and urban Australia.